Session date: 
12/01/2016 - 6:00am to 7:00am

Learning Objectives:

1)  Review risk of bleeding in atrial fibrillatin patients after PCI
2)  Review prior trials: ATLAS-ACS 2 TIMI and WOEST trials
3)  Review PIONEER AF-PCI trial

"*Credit (if available) is announced on the Group Home page.  All sessions are reviewed individually and credit is pulled for any that does not meet the criteria."

Presenter: 
Oludamilola Oluleye N.B.B.S.
Where did the idea for the course originate?: 
Florida
Please login or register to take this course.
Where did the idea for the course originate?: 
Florida